- ►chestpubs.org WH Geerts, GF Pineo, JA Heit, D Bergqvist, MR … - Chest, 2004 - chestjournal.chestpubs.org This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh
American College of Chest Physicians Conference on Antithrombotic and Thrombolytic
Therapy: Evidence-Based Guidelines. Grade 1 recommendations are strong and indicate ... Cited by 3401 - Related articles - BL Direct - All 58 versions
GP Clagett, FA Anderson, WH Geerts, J Heit, M … - CHEST- …, 1992 - Am Coll Chest Phys 3300 Dundee Road, Northbrook IL 60062. All rights Copyright 2007 by the American College
of Chest Physicians, Chest Physicians. It has been published monthly since 1935. CHEST is
the official journal of the American College of ... Copyright 1995 BY THE AMERICAN ... Cited by 1391 - Related articles - BL Direct - All 12 versions
JI Weitz - New England Journal of Medicine, 1997 - content.nejm.org Binding of the pentasaccharide to antithrombin causes a conformational change in antithrombin
that accelerates its interaction with thrombin and activated factor X (factor Xa) by about 1000
times. 5 The chief difference between unfractionated heparin and low-molecular-weight ... Cited by 1101 - Related articles - BL Direct - All 7 versions
- ►umn.edu [PDF] M Cohen, C Demers, EP Gurfinkel, AGG … - New England Journal …, 1997 - content.nejm.org Results At 14 days the risk of death, myocardial infarction, or recurrent angina was significantly
lower in the patients assigned to enoxaparin than in those assigned to unfractionated heparin
(16.6 percent vs. 19.8 percent, P = 0.019). At 30 days, the risk of this composite end point ... Cited by 1081 - Related articles - BL Direct - All 11 versions
- ►annals.org [PDF] G Merli, TE Spiro, CG Olsson, U Abildgaard, … - Annals of internal …, 2001 - Am Coll Physicians Background: Low-molecular-weight heparins administered sub- cutaneously once or twice daily
have been reported to be as safe and efficacious as intravenous unfractionated heparin in the
treat- ment of acute venous thromboembolic disease. Objective: To determine whether ... Cited by 223 - Related articles - BL Direct - All 11 versions
D Sources, D Extraction, D Synthesis - Ann Intern Med, 2001 - Am Coll Physicians Purpose: Evidence-based medicine guidelines based on veno- graphic end points recommend
in-hospital prophylaxis with low- molecular-weight heparin (LMWH) in patients having elective
hip surgery. Emerging data suggest that out-of-hospital use may offer additional ... Cited by 186 - Related articles - BL Direct - All 6 versions
- ►annals.org JR Leclerc, WH Geerts, L Desjardins, GH … - Annals of internal …, 1996 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Objective: To compare the effectiveness
and safety of fixed-dose enoxaparin and adjusted-dose warfarin in preventing venous ... Cited by 164 - Related articles - BL Direct - All 5 versions
- ►ottawa-anesthesia.org [PDF] RD Hull, GF Pineo, C Francis, D Bergqvist, … - Archives of Internal …, 2000 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 165 - Related articles - BL Direct - All 9 versions
RD Hull, GF Pineo, C Francis, D Bergqvist, … - Archives of Internal …, 2000 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 145 - Related articles - BL Direct - All 5 versions
- ►ejbjs.org CW Francis, VD Pellegrini Jr, S Totterman, AD Boyd … - The Journal of Bone and …, 1997 - JBJS The effectiveness and safety of warfarin were compared with those of a low-molecular-weight
heparin (dalteparin) for the prevention of deep-vein thrombosis after total hip arthroplasty in a
prospective, randomized, multi-institutional trial. Patients who were older than eighteen ... Cited by 129 - Related articles - BL Direct - All 4 versions
